Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Cell Calcium ; 51(1): 72-81, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22153127

RESUMO

Previous work from our laboratories demonstrated that the sugar-induced activation of plasma membrane H(+)-ATPase in Saccharomyces cerevisiae is dependent on calcium metabolism with the contribution of calcium influx from external medium. Our results demonstrate that a glucose-induced calcium (GIC) transporter, a new and still unidentified calcium carrier, sensitive to nifedipine and gadolinium and activated by glucose addition, seems to be partially involved in the glucose-induced activation of the plasma membrane H(+)-ATPase. On the other hand, the importance of calcium carriers that can release calcium from internal stores was analyzed in glucose-induced calcium signaling and activation of plasma membrane H(+)-ATPase, in experimental conditions presenting very low external calcium concentrations. Therefore the aim was also to investigate how the vacuole, through the participation of both Ca(2+)-ATPase Pmc1 and the TRP homologue calcium channel Yvc1 (respectively, encoded by the genes PMC1 and YVC1) contributes to control the intracellular calcium availability and the plasma membrane H(+)-ATPase activation in response to glucose. In strains presenting a single deletion in YVC1 gene or a double deletion in YVC1 and PMC1 genes, both glucose-induced calcium signaling and activation of the H(+)-ATPase are nearly abolished. These results suggest that Yvc1 calcium channel is an important component of this signal transduction pathway activated in response to glucose addition. We also found that by a still undefined mechanism Yvc1 activation seems to correlate with the changes in the intracellular level of IP(3). Taken together, these data demonstrate that glucose addition to yeast cells exposed to low external calcium concentrations affects calcium uptake and the activity of the vacuolar calcium channel Yvc1, contributing to the occurrence of calcium signaling connected to plasma membrane H(+)-ATPase activation.


Assuntos
Sinalização do Cálcio/efeitos dos fármacos , Membrana Celular/enzimologia , Glucose/farmacologia , ATPases Translocadoras de Prótons/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/enzimologia , Vacúolos/metabolismo , Compostos de Boro/farmacologia , Cálcio/metabolismo , Membrana Celular/efeitos dos fármacos , Ácido Egtázico/farmacologia , Ativação Enzimática/efeitos dos fármacos , Espaço Extracelular/efeitos dos fármacos , Espaço Extracelular/metabolismo , Inositol 1,4,5-Trifosfato/metabolismo , Modelos Biológicos , Mutação/genética , Nifedipino/farmacologia , Saccharomyces cerevisiae/citologia , Saccharomyces cerevisiae/efeitos dos fármacos , Canais de Cátion TRPC/metabolismo , Vacúolos/efeitos dos fármacos
2.
FEBS Lett ; 532(3): 324-32, 2002 Dec 18.
Artigo em Inglês | MEDLINE | ID: mdl-12482587

RESUMO

The PKC1 gene in the yeast Saccharomyces cerevisiae encodes for protein kinase C which is known to control a MAP kinase cascade consisting of different kinases: Bck1, Mkk1 and Mkk2, and Mpk1. This cascade affects the cell wall integrity but the phenotype of pkc1Delta mutants suggests additional targets that have not yet been identified [Heinisch et al., Mol. Microbiol. 32 (1999) 671-680]. The pkc1Delta mutant, as opposed to other mutants in the MAP kinase cascade, displays defects in the control of carbon metabolism. One of them occurs in the derepression of SUC2 gene after exhaustion of glucose from the medium, suggesting an involvement of Pkc1p in the derepression process that is not shared by the downstream MAP kinase cascade. In this work, we demonstrate that Pkc1p is required for the increase of the activity of enzymatic systems during the derepression process. We observed that Pkc1p is involved in the derepression of invertase and alcohol dehydrogenase activities. On the other hand, it seems not to be necessary for the derepression of the enzymes of the GAL system. Our results suggest that Pkc1p is acting through the main glucose repression pathway, since introduction of an additional mutation in the PKC1 gene in yeast strains already presenting mutations in the HXKII or MIG1 genes does not interfere with the typical derepressed phenotype observed in these single mutants. Moreover, our data indicate that Pkc1p participates in this process through the control of the cellular localization of the Mig1 transcriptional factor.


Assuntos
Proteína Quinase C/metabolismo , Saccharomyces cerevisiae/enzimologia , Ágar/farmacologia , Álcool Desidrogenase/metabolismo , Northern Blotting , Western Blotting , Divisão Celular , Proteínas de Ligação a DNA/metabolismo , Relação Dose-Resposta a Droga , Epitopos , Glucose/metabolismo , Glicosídeo Hidrolases/metabolismo , Proteínas de Fluorescência Verde , Proteínas Luminescentes/metabolismo , Mutação , Fenótipo , Ligação Proteica , Proteína Quinase C/genética , RNA/metabolismo , Proteínas Repressoras/metabolismo , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae , Fatores de Tempo , Transcrição Gênica , beta-Frutofuranosidase
3.
FEMS Yeast Res ; 2(2): 93-102, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12702297

RESUMO

The PKC1 gene in the yeast Saccharomyces cerevisiae encodes protein kinase C that is known to control a mitogen-activated protein (MAP) kinase cascade consisting of Bck1, Mkk1 and Mkk2, and Mpk1. This cascade affects the cell wall integrity but the phenotype of Pkc1 mutants suggests additional targets which have not yet been identified. We show that a pkc1Delta mutant, as opposed to mutants in the MAP kinase cascade, displays two major defects in the control of carbon metabolism. It shows a delay in the initiation of fermentation upon addition of glucose and a defect in derepression of SUC2 gene after exhaustion of glucose from the medium. After addition of glucose the production of both ethanol and glycerol started very slowly. The V(max) of glucose transport dropped considerably and Northern blot analysis showed that induction of the HXT1, HXT2 and HXT4 genes was strongly reduced. Growth of the pkc1Delta mutant was absent on glycerol and poor on galactose and raffinose. Oxygen uptake was barely present. Derepression of invertase activity and SUC2 transcription upon transfer of cells from glucose to raffinose was deficient in the pkc1Delta mutant as opposed to the wild-type. Our results suggest an involvement of Pkc1p in the control of carbon metabolism which is not shared by the downstream MAP kinase cascade.


Assuntos
Glucose/metabolismo , Glicosídeo Hidrolases/genética , Proteína Quinase C/fisiologia , Saccharomyces cerevisiae/enzimologia , Fatores de Transcrição/biossíntese , Fatores de Transcrição Hélice-Alça-Hélice Básicos , Northern Blotting , Regulação Fúngica da Expressão Gênica , Mutação , Proteína Quinase C/genética , Proteínas Repressoras/metabolismo , Saccharomyces cerevisiae/genética , Transdução de Sinais/fisiologia , Fatores de Transcrição/genética , Transcrição Gênica , beta-Frutofuranosidase
4.
Microbiology (Reading) ; 147(Pt 10): 2849-2855, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11577163

RESUMO

The glucose-induced activation of plasma membrane ATPase from Saccharomyces cerevisiae was first described by Serrano in 1983. Many aspects of this signal transduction pathway are still obscure. In this paper, evidence is presented for the involvement of Snf3p as the glucose sensor related to this activation process. It is shown that, in addition to glucose detection by Snf3p, sugar transport is also necessary for activation of the ATPase. The participation of the G protein, Gpa2p, in transducing the internal signal (phosphorylated sugars) is also demonstrated. Moreover, the involvement of protein kinase C in the regulation of ATPase activity is confirmed. Finally, a model pathway is presented for sensing and transmission of the glucose activation signal of the yeast H(+)-ATPase.


Assuntos
Subunidades alfa de Proteínas de Ligação ao GTP , Regulação Fúngica da Expressão Gênica , Glucose/metabolismo , ATPases Translocadoras de Prótons/metabolismo , Proteínas de Saccharomyces cerevisiae , Saccharomyces cerevisiae/enzimologia , Transdução de Sinais , Meios de Cultura , Ativação Enzimática , Proteínas Fúngicas/metabolismo , Proteínas Heterotriméricas de Ligação ao GTP/metabolismo , Proteínas de Membrana/metabolismo , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Proteínas de Transporte de Monossacarídeos/metabolismo , Proteína Quinase C/metabolismo , ATPases Translocadoras de Prótons/genética , Saccharomyces cerevisiae/crescimento & desenvolvimento
5.
Appl Environ Microbiol ; 64(2): 564-8, 1998 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9464394

RESUMO

As is the case for Saccharomyces boulardii, Saccharomyces cerevisiae W303 protects Fisher rats against cholera toxin (CT). The addition of glucose or dinitrophenol to cells of S. boulardii grown on a nonfermentable carbon source activated trehalase in a manner similar to that observed for S.cerevisiae. The addition of CT to the same cells also resulted in trehalase activation. Experiments performed separately on the A and B subunits of CT showed that both are necessary for activation. Similarly, the addition of CT but not of its separate subunits led to a cyclic AMP (cAMP) signal in both S. boulardii and S. cerevisiae. These data suggest that trehalase stimulation by CT probably occurred through the cAMP-mediated protein phosphorylation cascade. The requirement of CT subunit B for both the cAMP signal and trehalase activation indicates the presence of a specific receptor on the yeasts able to bind to the toxin, a situation similar to that observed for mammalian cells. This hypothesis was reinforced by experiments with 125I-labeled CT showing specific binding of the toxin to yeast cells. The adhesion of CT to a receptor on the yeast surface through the B subunit and internalization of the A subunit (necessary for the cAMP signal and trehalase activation) could be one more mechanism explaining protection against the toxin observed for rats treated with yeasts.


Assuntos
Toxina da Cólera/farmacologia , Saccharomyces cerevisiae/metabolismo , Saccharomyces/metabolismo , Animais , Toxina da Cólera/metabolismo , AMP Cíclico/biossíntese , Masculino , Ratos , Ratos Endogâmicos F344 , Saccharomyces/efeitos dos fármacos , Saccharomyces cerevisiae/efeitos dos fármacos , Trealase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA